Proteolysis of multiple myelin basic protein isoforms after neurotrauma: characterization by mass spectrometry

Neurotrauma, as in the case of traumatic brain injury, promotes protease over‐activation characterized by the select fragmentation of brain proteins. The resulting polypeptides are indicators of biochemical processes, which can be used to study post‐injury dynamics and may also be developed into biomarkers. To this end, we devised a novel mass spectrometry approach to characterize post‐injury calpain proteolytic processing of myelin basic protein (MBP), a biomarker of brain injury that denotes white matter damage and recovery. Our approach exceeds conventional immunological assays in its deconvolution of multiple protein isoforms, its absolute quantification of proteolytic fragments and its polypeptide selectivity. We quantified and characterized post‐injury proteolytic processing of all MBP isoforms identified in adult rat cortex. Further, the translation of calpain‐cleaved MBP into CSF was verified following brain injury. We ascertained that the exon‐6 sequence of MBP resulted in a characteristic shift in gel migration for intact and fragmented protein alike. We also found evidence for a second post‐TBI cleavage event within exon‐2 and for the dimerization of the post‐TBI 4.3 kDa fragment. Ultimately, the novel methodology described here can be used to study MBP dynamics and other similar proteolytic events of relevance to brain injury and other CNS processes.

[1]  N. Banik,et al.  Mechanism of Myelin Breakdown in Experimental Demyelination: A Putative Role for Calpain , 2001, Neurochemical Research.

[2]  J. Boggs,et al.  Myelin basic protein: a multifunctional protein , 2006, Cellular and Molecular Life Sciences CMLS.

[3]  E. Hogan,et al.  A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro: inhibition of a proteinase (calpain) prevents myelin and cytoskeletal protein degradation , 1997, Brain Research.

[4]  D. Thomas,et al.  SERUM-MYELIN-BASIC-PROTEIN ASSAY IN DIAGNOSIS AND PROGNOSIS OF PATIENTS WITH HEAD INJURY , 1978, The Lancet.

[5]  M. Cuzner,et al.  Myelin basic protein isoforms in myelinating and remyelinating rat brain aggregate cultures , 1999, Journal of neuroscience research.

[6]  Michael J MacCoss,et al.  Quantitative comparison of proteomic data quality between a 2D and 3D quadrupole ion trap. , 2006, Analytical chemistry.

[7]  R. Brady,et al.  Elevated neutral protease activity in myelin from brains of patients with multiple sclerosis , 1984, Annals of neurology.

[8]  George Harauz,et al.  Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis. , 2004, Micron.

[9]  J. Losy,et al.  Biological markers to confirm diagnosis and monitor the therapy in multiple sclerosis patients. , 2001, Folia neuropathologica.

[10]  P. Kochanek,et al.  Serum Biomarkers after Traumatic and Hypoxemic Brain Injuries: Insight into the Biochemical Response of the Pediatric Brain to Inflicted Brain Injury , 2006, Developmental Neuroscience.

[11]  H. McFarland,et al.  Multiple sclerosis: Re‐expression of a developmental gene in chronic lesions correlates with remyelination , 1997, Annals of neurology.

[12]  E. Sribnick,et al.  Calpain inhibitor prevented apoptosis and maintained transcription of proteolipid protein and myelin basic protein genes in rat spinal cord injury , 2003, Journal of Chemical Neuroanatomy.

[13]  K. Mikoshiba,et al.  Novel Isoforms of Mouse Myelin Basic Protein Predominantly Expressed in Embryonic Stage , 1993, Journal of neurochemistry.

[14]  E. Hogan,et al.  Inhibition of Proteolysis by a Cyclooxygenase Inhibitor, Indomethacin , 2000, Neurochemical Research.

[15]  F. Tortella,et al.  Extensive degradation of myelin basic protein isoforms by calpain following traumatic brain injury , 2006, Journal of neurochemistry.

[16]  S. Gygi,et al.  Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Tonali,et al.  Cerebrospinal fluid markers in multiple sclerosis: an overview , 1998, Multiple sclerosis.

[18]  Marion E. Smith,et al.  The role of proteolytic enzymes in demyelination in experimental allergic encephalomyelitis , 1977, Neurochemical Research.

[19]  T. Boyer,et al.  Identification of a short form of ubiquitin-specific protease 3 that is a repressor of rat glutathione S-transferase gene expression. , 2006, The Biochemical journal.

[20]  W. Norton,et al.  Isolation and Characterization of Myelin , 1977 .

[21]  Jasminka Godovac-Zimmermann,et al.  Perspectives in spicing up proteomics with splicing , 2005, Proteomics.

[22]  T. Saido,et al.  A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Boggs,et al.  Adhesion of acidic lipid vesicles by 21.5 kDa (recombinant) and 18.5 kDa isoforms of myelin basic protein. , 2000, Biochimica et biophysica acta.

[24]  C. Boulias,et al.  The isolation and characterization of four myelin basic proteins from the unbound fraction during CM52 chromatography. , 1995, Archives of biochemistry and biophysics.

[25]  F. Tortella,et al.  Novel Differential Neuroproteomics Analysis of Traumatic Brain Injury in Rats* , 2006, Molecular & Cellular Proteomics.

[26]  R. Hayes,et al.  A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels. , 2004, Journal of neurotrauma.

[27]  M.,et al.  The Isolation , Characterization , and Lipid-aggregating Properties of a Citrulline Containing Myelin Basic Protein * , 2001 .

[28]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .

[29]  S. Scherer,et al.  On the molecular architecture of myelinated fibers , 2000, Histochemistry and Cell Biology.

[30]  Y. Nishizuka,et al.  Studies on the phosphorylation of myelin basic protein by protein kinase C and adenosine 3':5'-monophosphate-dependent protein kinase. , 1985, The Journal of biological chemistry.

[31]  M. Katsuki,et al.  Overexpression of a minor component of myelin basic protein isoform (17.2 kDa) can restore myelinogenesis in transgenic shiverer mice , 1998, Brain Research.

[32]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[33]  E. Bongarzone,et al.  New insights on the biology of myelin basic protein gene: The neural‐Immune connection , 2000, Journal of neuroscience research.

[34]  D. Wood,et al.  The isolation, characterization, and lipid-aggregating properties of a citrulline containing myelin basic protein. , 1989, The Journal of biological chemistry.

[35]  F. Tortella,et al.  Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis. , 2006, The Biochemical journal.

[36]  A. Omori,et al.  Study of expression of myelin basic proteins (MBPs) in developing rat brain using a novel antibody reacting with four major isoforms of MBP , 2002, Journal of neuroscience research.

[37]  D. N. Perkins,et al.  Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.

[38]  D. Meaney,et al.  Diffuse Axonal Injury in Head Trauma , 2003, The Journal of head trauma rehabilitation.

[39]  J. Määttä,et al.  Detection of myelin basic protein isoforms by organic concentration. , 1997, Biochemical and biophysical research communications.

[40]  L L Needham,et al.  Isotope dilution--mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. , 1996, Clinical chemistry.

[41]  J R Yates,et al.  Emerging tandem-mass-spectrometry techniques for the rapid identification of proteins. , 1997, Trends in biotechnology.

[42]  Peter Tompa,et al.  On the Sequential Determinants of Calpain Cleavage* , 2004, Journal of Biological Chemistry.

[43]  Takeshi Itoh,et al.  Alternative splicing in human transcriptome: functional and structural influence on proteins. , 2006, Gene.